Robeco Institutional Asset Management
ANIP icon

Robeco Institutional Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Robeco Institutional Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,254
Closed -$225K – 918
2024
Q1 		$225K Hold
3,254
– – ﹤0.01% 908
2023
Q4 		$179K Hold
3,254
– – ﹤0.01% 915
2023
Q3 		$189K Buy
+3,254
New +$188K ﹤0.01% 929
2019
Q4 		– Sell
-1,264
Closed -$92K – 971
2019
Q3 		$92K Buy
+1,264
New +$94.6K ﹤0.01% 936

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robeco Institutional Asset Management's ANIP Position: Q2 2024 in Review

Robeco Institutional Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 3,254 shares — an estimated $225K sold.

Robeco Institutional Asset Management first reported a position in ANIP in Q3 2019 and held it in 4 quarters. The position peaked at $225K in Q1 2024. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • Robeco Institutional Asset Management reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 3,254 ANI Pharmaceuticals shares in Q2 2024, an estimated $225K.
  • Robeco Institutional Asset Management first reported a position in ANI Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Robeco Institutional Asset Management's ANI Pharmaceuticals position peaked at $225K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2024, filed 23 Jul 2024.